Trade Summary

10 months ago, Cordova Ashley, serving as CEO at Novocure Ltd (NVCR), purchased 81,550 shares at $12.22 per share, for a total transaction value of $996,859.00. Following this transaction, Cordova Ashley now holds 437,569 shares of NVCR.

This purchase represents a 23.00% increase in Cordova Ashley's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, September 5, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 8, 2025 at 7:10 AM ET, 3 days after the trade was made.

Novocure Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.